{"id":"NCT00674154","sponsor":"University of Aarhus","briefTitle":"Effect of Vitamin D Treatment in Primary Hyperparathyroidism","officialTitle":"Effect of Vitamin D Treatment in Primary Hyperparathyroidism","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-05","primaryCompletion":"2013-08","completion":"2013-08","firstPosted":"2008-05-07","resultsPosted":"2013-10-16","lastUpdate":"2013-11-18"},"enrollment":46,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Vitamin D Deficiency","Primary Hyperparathyroidism","Hypercalcemia"],"interventions":[{"type":"DRUG","name":"Cholecalciferol","otherNames":["vitamin D"]}],"arms":[{"label":"Vitamin D group","type":"EXPERIMENTAL"},{"label":"Placebo group","type":"PLACEBO_COMPARATOR"}],"summary":"The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.","primaryOutcome":{"measure":"Decrease in Preoperative P-PTH","timeFrame":"25 weeks","effectByArm":[{"arm":"Vitamin D","deltaMin":-2.2,"sd":0.7},{"arm":"Placebo","deltaMin":0.2,"sd":1}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":1,"countries":["Denmark"]},"refs":{"pmids":["35018442"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":20},"commonTop":["Eye infection","Lower leg cramp","Pneumonia","Abdominal pain","Steatosis hepatis"]}}